SHP2/CDK4-IN-1 is a dual inhibitor of SHP2 and CDK4 with IC50 values of 4.3 and 18.2 nM, respectively; it effectively induces G0/G1 cell cycle arrest and inhibits the proliferation of triple-negative breast cancer (TNBC) cells; it demonstrates significant antitumor activity in the EMT6 syngeneic mouse model; it can be used for the research of triple-negative breast cancer (TNBC).